|
Acelyrin
|
16.55
|
4,35
|
-0,91%
|
4,41
|
4,29 - 4,44
|
|
Achari Ventures Holdings Corp. I
|
08/04
|
10,93
|
0,00%
|
10,93
|
10,93 - 10,93
|
|
Achari Ventures Holdings Corp. I Units Cons Of 1 Sh +
|
04/03
|
12,03
|
0,00%
|
0
|
---
|
|
Achari Ventures Holdings Corp. I Warrant 2021-
|
08/04
|
0,0221
|
0,00%
|
0,0221
|
0,0221 - 0,0221
|
|
Achieve Life Sciences
|
16.56
|
4,875
|
-2,50%
|
4,93
|
4,8 - 5,07
|
|
Achilles Therapeutics Plc Sponsored Adr
|
17.01
|
0,954
|
+0,65%
|
0,92
|
0,9101 - 0,96
|
|
Aci Worldwide
|
17.01
|
37,76
|
+0,69%
|
37,37
|
37,37 - 37,82
|
|
Aclarion
|
16.51
|
0,325
|
+0,15%
|
0,3128
|
0,3128 - 0,326
|
|
Aclarion, Inc. Warrant 2022- On Aclarion
|
17/05
|
0,03
|
-14,29%
|
0,03
|
0,0299 - 0,03
|
|
Aclaris Therapeutics
|
16.57
|
1,175
|
-1,26%
|
1,17
|
1,15 - 1,19
|
|
Acm Research
|
17.02
|
23,5546
|
-1,03%
|
23,86
|
23,4035 - 24,1213
|
|
Acnb
|
15.47
|
33,73
|
-0,56%
|
33,68
|
33,165 - 34,2115
|
|
Acorda Therapeutics
|
11/04
|
0,661
|
0,00%
|
0,661
|
0,661 - 0,661
|
|
Acorq
|
11/04
|
0,661
|
0,00%
|
0,661
|
0,661 - 0,661
|
|
Acri Capital Acquisition
|
15.39
|
11,28
|
+0,53%
|
11,28
|
11,28 - 11,28
|
|
Acri Capital Acquisition Corporation Units Cons Of
|
03/05
|
11,65
|
0,00%
|
0
|
---
|
|
Acri Capital Acquisition Corporation Warrant 2022- On
|
01/05
|
0,07
|
0,00%
|
0
|
---
|
|
Acrivon Therapeutics
|
16.55
|
8,85
|
-0,45%
|
8,99
|
8,72 - 9,1
|
|
Actelis Networks
|
16.38
|
0,5035
|
-3,36%
|
0,5
|
0,5 - 0,5588
|
|
Acumen Pharmaceuticals
|
16.48
|
3,8
|
+4,11%
|
3,69
|
3,645 - 3,83
|